Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell DexCom, Inc. (DXCM) – DexCom, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

DXCM trades at $63.25, up 1.66% on the day, amid a bearish technical signal but strong fundamental performance. The company has consistently beaten earnings estimates in recent quarters, with Q4 2025 EPS of $0.68 exceeding the $0.65 expectation. Revenue and net income have shown steady growth, with 2024 revenue reaching $4.03B and net income at $576.20M. Positive developments include Medicare coverage expansion and the new G7 15-day sensor, though technical indicators suggest near-term price pressure.
The outlook for DXCM remains positive based on strong fundamentals and analyst consensus, with a price target of $84.63 implying significant upside. Key opportunities include sustained demand for CGM systems and product innovation. Risks involve rising competition, margin pressures from manufacturing investments, and market volatility. The stock's current valuation metrics, including a P/E of 30.24, reflect growth expectations but warrant monitoring for sustainability.
Read full analysis

Key Stats

  • Market Cap
    $24.33B
  • Sector
    Health
  • 3M Drawdown
    -16.78%
  • Enterprise Value
    $23.72B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    60 days
$63.27
52W Low: $54.84
10 Nov 2025
52W High: $89.53
28 Jul 2025

DexCom, Inc. (DXCM) is currently valued at a market capitalization of $24.33B, with an enterprise value of $23.72B. Over the past 52 weeks, DexCom, Inc. has traded between a low of $54.84 and a high of $89.53, highlighting its annual price range. Over the past three months, DexCom, Inc. has recorded a drawdown of -16.78%, reflecting recent price volatility. DexCom, Inc. offers a dividend yield of -. On average, investors hold DexCom, Inc. for approximately 60 days, indicating typical investor behavior on the platform.

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.


Technical Indicators
|
|
|
Overall Summary
Bearish (4)Neutral (9)Bullish (14)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $24.33B
  • Sector
    Health
  • 3M Drawdown
    -16.78%
  • Enterprise Value
    $23.72B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    60 days
$63.27
52W Low: $54.84
10 Nov 2025
52W High: $89.53
28 Jul 2025

DexCom, Inc. (DXCM) is currently valued at a market capitalization of $24.33B, with an enterprise value of $23.72B. Over the past 52 weeks, DexCom, Inc. has traded between a low of $54.84 and a high of $89.53, highlighting its annual price range. Over the past three months, DexCom, Inc. has recorded a drawdown of -16.78%, reflecting recent price volatility. DexCom, Inc. offers a dividend yield of -. On average, investors hold DexCom, Inc. for approximately 60 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!